SCHEMBL24607337

SCHEMBL24607337

Cc1ccc2[nH]c(=O)n(C)c2c1Br

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A2 P19784 1/20 0.46
CSNK2B P67870 1/20 0.46
CSNK2A1 P68400 1/20 0.46
LMNA P02545 3/20 0.42
DAO P14920 3/20 0.41
PDE3B Q13370 2/20 0.40
PDE3A Q14432 2/20 0.40
DPP4 P27487 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
ADORA2A P29274 1/20 0.40
ADORA2B P29275 1/20 0.40
ADORA1 P30542 1/20 0.40
GAA P10253 2/20 0.38
ALDH1A1 P00352 1/20 0.38
KDM4E B2RXH2 1/20 0.36
PGR P06401 1/20 0.35
MEN1 O00255 1/20 0.34
PABPC1 P11940 1/20 0.34
KMT2A Q03164 1/20 0.34
MAOB P27338 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29751529 1.00 CSNK2A2 (0.46) CSNK2A2CSNK2BCSNK2A1LMNADAO
SCHEMBL22972503 0.81 PDE3B (0.49) CSNK2A2CSNK2BCSNK2A1LMNADAO
SCHEMBL29751458 0.81 DAO (0.47) CSNK2A2CSNK2BCSNK2A1LMNADAO
SCHEMBL24058145 0.81 DAO (0.47) CSNK2A2CSNK2BCSNK2A1LMNADAO
SCHEMBL21050770 0.79 PDE3B (0.43) CSNK2A2CSNK2BCSNK2A1LMNADAO
SCHEMBL23832583 0.78 CSNK2A2 (0.42) CSNK2A2CSNK2BCSNK2A1LMNAPDE3B
SCHEMBL24854116 0.76 LMNA (0.40) CSNK2A2CSNK2BCSNK2A1LMNADAO
SCHEMBL13015482 0.76 PDE3B (0.40) LMNADAOPDE3BPDE3ADPP4
SCHEMBL24854272 0.76 LMNA (0.40) CSNK2A2CSNK2BCSNK2A1LMNADAO
SCHEMBL13015480 0.74 DAO (0.66) LMNADAOPDE3BPDE3ADPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022147465-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2022-07-07 WO disclosed